AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
AAPL   373.85 (+2.68%)
MSFT   210.70 (+2.15%)
FB   240.28 (+2.94%)
GOOGL   1,499.65 (+2.02%)
AMZN   3,057.04 (+5.77%)
NVDA   393.57 (+2.36%)
CGC   16.94 (+2.98%)
BABA   240.00 (+7.33%)
MU   50.92 (+2.19%)
GE   7.00 (+2.64%)
TSLA   1,371.58 (+13.48%)
AMD   53.40 (+2.03%)
T   30.49 (+1.36%)
ACB   12.18 (-0.73%)
F   6.19 (+2.31%)
GILD   76.76 (+0.54%)
DIS   114.43 (+2.01%)
BAC   23.66 (+1.59%)
NFLX   493.81 (+3.55%)
BA   187.91 (+3.93%)
Log in

NASDAQ:TBPHTheravance Biopharma News Headlines

$20.52
-0.14 (-0.68 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$20.32
Now: $20.52
$21.21
50-Day Range
$20.52
MA: $24.35
$27.73
52-Week Range
$15.72
Now: $20.52
$31.54
Volume368,500 shs
Average Volume450,359 shs
Market Capitalization$1.29 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.43

Headlines

Theravance Biopharma (NASDAQ TBPH) News Headlines

Source:
DateHeadline
Theravance Biopharma Inc (NASDAQ:TBPH) Expected to Announce Quarterly Sales of $23.07 MillionTheravance Biopharma Inc (NASDAQ:TBPH) Expected to Announce Quarterly Sales of $23.07 Million
www.americanbankingnews.com - July 5 at 3:40 AM
Zacks: Analysts Anticipate Theravance Biopharma Inc (NASDAQ:TBPH) Will Announce Earnings of -$0.95 Per ShareZacks: Analysts Anticipate Theravance Biopharma Inc (NASDAQ:TBPH) Will Announce Earnings of -$0.95 Per Share
www.americanbankingnews.com - July 3 at 5:44 PM
Theravance Biopharma Inc (NASDAQ:TBPH) Receives Consensus Rating of "Hold" from BrokeragesTheravance Biopharma Inc (NASDAQ:TBPH) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - July 3 at 1:55 AM
Theravance Biopharma appoints Deepika Pakianathan to BODTheravance Biopharma appoints Deepika Pakianathan to BOD
seekingalpha.com - July 2 at 11:04 AM
Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of DirectorsTheravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors
finance.yahoo.com - July 2 at 6:04 AM
Theravance Biopharma (NASDAQ:TBPH) Downgraded by ValuEngine to HoldTheravance Biopharma (NASDAQ:TBPH) Downgraded by ValuEngine to Hold
www.marketbeat.com - July 2 at 3:56 AM
Hedge Funds Have Never Been More Bullish On Theravance Biopharma Inc (TBPH)Hedge Funds Have Never Been More Bullish On Theravance Biopharma Inc (TBPH)
finance.yahoo.com - June 29 at 6:12 PM
Theravance Doses First Patient in Phase II Coronavirus StudyTheravance Doses First Patient in Phase II Coronavirus Study
finance.yahoo.com - June 26 at 1:29 PM
Dosing underway in mid-stage study of Theravance drug for COVID-19Dosing underway in mid-stage study of Theravance drug for COVID-19
seekingalpha.com - June 25 at 9:27 AM
Theravance Biopharma (NASDAQ:TBPH) Receives Daily Coverage Optimism Rating of -3.53Theravance Biopharma (NASDAQ:TBPH) Receives Daily Coverage Optimism Rating of -3.53
www.americanbankingnews.com - June 18 at 11:28 PM
Short Interest in Theravance Biopharma Inc (NASDAQ:TBPH) Decreases By 27.4%Short Interest in Theravance Biopharma Inc (NASDAQ:TBPH) Decreases By 27.4%
www.americanbankingnews.com - June 18 at 4:43 PM
TBPH Makes Notable Cross Below Critical Moving AverageTBPH Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - June 17 at 12:55 PM
Benzingas Top Upgrades, Downgrades For June 15, 2020Benzinga's Top Upgrades, Downgrades For June 15, 2020
finance.yahoo.com - June 15 at 1:10 PM
Theravance Biopharma (NASDAQ:TBPH) Coverage Initiated at Morgan StanleyTheravance Biopharma (NASDAQ:TBPH) Coverage Initiated at Morgan Stanley
www.americanbankingnews.com - June 15 at 10:16 AM
$23.07 Million in Sales Expected for Theravance Biopharma Inc (NASDAQ:TBPH) This Quarter$23.07 Million in Sales Expected for Theravance Biopharma Inc (NASDAQ:TBPH) This Quarter
www.americanbankingnews.com - June 13 at 2:36 AM
 Brokerages Anticipate Theravance Biopharma Inc (NASDAQ:TBPH) to Announce -$1.02 Earnings Per Share Brokerages Anticipate Theravance Biopharma Inc (NASDAQ:TBPH) to Announce -$1.02 Earnings Per Share
www.americanbankingnews.com - June 11 at 9:16 PM
Theravance Bio (TBPH) Down 2.7% Since Last Earnings Report: Can It Rebound?Theravance Bio (TBPH) Down 2.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 5 at 1:11 PM
Cumberland Pharmaceuticals: All-Time Lows Look DeservedCumberland Pharmaceuticals: All-Time Lows Look Deserved
seekingalpha.com - May 28 at 9:46 AM
Theravance Biopharma Inc (TBPH) Q1 2020 Earnings Call TranscriptTheravance Biopharma Inc (TBPH) Q1 2020 Earnings Call Transcript
www.fool.com - May 8 at 2:58 PM
Theravance Biopharma (TBPH) Reports Q1 Loss, Tops Revenue EstimatesTheravance Biopharma (TBPH) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 7 at 4:42 PM
Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q1 2020 Results - Earnings Call TranscriptTheravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 7 at 4:42 PM
Edited Transcript of TBPH earnings conference call or presentation 6-May-20 9:00pm GMTEdited Transcript of TBPH earnings conference call or presentation 6-May-20 9:00pm GMT
finance.yahoo.com - May 7 at 4:42 PM
Will Theravance Biopharma (TBPH) Report Negative Earnings Next Week? What You Should KnowWill Theravance Biopharma (TBPH) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - April 29 at 3:34 PM
Here's What We Think About Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO PayHere's What We Think About Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Pay
finance.yahoo.com - April 28 at 2:31 PM
Will Theravance Biopharma (TBPH) Report Negative Q1 Earnings? What You Should KnowWill Theravance Biopharma (TBPH) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 28 at 2:31 PM
Theravance Biopharma to Report First Quarter 2020 Financial Results on May 6, 2020Theravance Biopharma to Report First Quarter 2020 Financial Results on May 6, 2020
finance.yahoo.com - April 28 at 8:05 AM
Dosing underway in study of Theravance drug for COVID-19Dosing underway in study of Theravance drug for COVID-19
seekingalpha.com - April 23 at 10:11 AM
Theravance Bio doses first subject in early-stage TD-0903 study for COVD-19Theravance Bio doses first subject in early-stage TD-0903 study for COVD-19
seekingalpha.com - April 23 at 10:11 AM
Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and ColitisTheravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis
finance.yahoo.com - April 20 at 8:04 AM
Theravance Bio (TBPH) Up 2.1% Since Last Earnings Report: Can It Continue?Theravance Bio (TBPH) Up 2.1% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - March 25 at 3:29 PM
Stocks To Watch: Theravance Biopharma Sees Relative Strength Rating Jump To 94Stocks To Watch: Theravance Biopharma Sees Relative Strength Rating Jump To 94
finance.yahoo.com - March 23 at 8:26 PM
Theravance Biopharma is Now Oversold (TBPH)Theravance Biopharma is Now Oversold (TBPH)
www.nasdaq.com - March 17 at 12:11 AM
Theravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse NotesTheravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse Notes
finance.yahoo.com - March 2 at 7:27 AM
Analysts Have Lowered Expectations For Theravance Biopharma, Inc. After Its Latest ResultsAnalysts Have Lowered Expectations For Theravance Biopharma, Inc. After Its Latest Results
finance.yahoo.com - February 27 at 3:07 PM
Edited Transcript of TBPH earnings conference call or presentation 24-Feb-20 10:00pm GMTEdited Transcript of TBPH earnings conference call or presentation 24-Feb-20 10:00pm GMT
finance.yahoo.com - February 25 at 7:58 AM
Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business UpdateTheravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
www.finanznachrichten.de - February 24 at 9:16 PM
Theravance Biopharma EPS misses by $0.06, beats on revenueTheravance Biopharma EPS misses by $0.06, beats on revenue
seekingalpha.com - February 24 at 9:16 PM
Theravance Biopharma (TBPH) Reports Q4 Loss, Tops Revenue EstimatesTheravance Biopharma (TBPH) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - February 24 at 9:16 PM
Theravance Biopharma Announces Presentations at Upcoming Investor ConferencesTheravance Biopharma Announces Presentations at Upcoming Investor Conferences
finance.yahoo.com - February 18 at 8:57 AM
Analysts Estimate Theravance Biopharma (TBPH) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Theravance Biopharma (TBPH) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - February 17 at 5:50 PM
Why Theravance Biopharma Shares Are Sinking TodayWhy Theravance Biopharma Shares Are Sinking Today
www.nasdaq.com - February 12 at 1:04 PM
Theravance Bio down 2% premarket after pricing stock offeringTheravance Bio down 2% premarket after pricing stock offering
seekingalpha.com - February 12 at 8:03 AM
How Does Investing In Theravance Biopharma, Inc. (NASDAQ:TBPH) Impact The Volatility Of Your Portfolio?How Does Investing In Theravance Biopharma, Inc. (NASDAQ:TBPH) Impact The Volatility Of Your Portfolio?
finance.yahoo.com - February 11 at 7:18 PM
20 Stocks Moving In Mondays After-Hours Session20 Stocks Moving In Monday's After-Hours Session
www.msn.com - February 10 at 11:07 PM
BRIEF-Theravance Biopharma Announces Proposed Public Offering Of Ordinary SharesBRIEF-Theravance Biopharma Announces Proposed Public Offering Of Ordinary Shares
www.msn.com - February 10 at 6:07 PM
Theravance readies $150M stock offering; shares down 5% after hoursTheravance readies $150M stock offering; shares down 5% after hours
seekingalpha.com - February 10 at 6:07 PM
Theravance Biopharma Announces Proposed Public Offering of Ordinary SharesTheravance Biopharma Announces Proposed Public Offering of Ordinary Shares
www.prnewswire.com - February 10 at 6:07 PM
3 “Strong Buy” Biotech Stocks That Can Inject a Healthy Dose of Upside3 “Strong Buy” Biotech Stocks That Can Inject a Healthy Dose of Upside
finance.yahoo.com - January 19 at 9:27 AM
AstraZeneca's Triple-Combo COPD Inhaler Gets China's NodAstraZeneca's Triple-Combo COPD Inhaler Gets China's Nod
finance.yahoo.com - December 24 at 12:12 PM
Pfizer licenses Theravances JAK inhibitors for skin conditionsPfizer licenses Theravance's JAK inhibitors for skin conditions
seekingalpha.com - December 23 at 9:20 AM
This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.